Suppr超能文献

新辅助化疗能否改变宫颈癌淋巴结清扫的范围?一项大规模回顾性研究。

Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? A large-scale retrospective study.

作者信息

Hu Ting, Li Xiong, Zhang Qinghua, Huang Kecheng, Jia Yao, Yang Ru, Tang Fangxu, Tian Qiang, Ma Ding, Li Shuang

机构信息

Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.

Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China; Department of Gynecology & Obstetrics, the Central Hospital of Wuhan, Wuhan, P.R. China.

出版信息

PLoS One. 2015 Apr 10;10(4):e0123539. doi: 10.1371/journal.pone.0123539. eCollection 2015.

Abstract

BACKGROUND

The effect of neoadjuvant chemotherapy (NACT) on topographical distribution patterns of lymph node metastasis in cervical cancer was unknown.

METHODS

Patients with FIGO stage IB1-IIB who underwent radical surgery with or without NACT were enrolled (3527 patients). A matched-case comparison design was used to compare the effects of NACT on lymph node metastasis.

RESULTS

We analyzed groups of 167 and 140 patients who were diagnosed with lymph node metastasis in the matched primary surgery group and NACT group, respectively, and no significant difference was observed (p = 0.081). The incidence of lymph node metastasis was significantly decreased in the NACT-responsive group compared to the non-responsive group (18.4% vs. 38.6%, P<0.001). The metastatic rates for every lymph node group also declined in the NACT-responsive group except for the deep inguinal and the para-aortic lymph node groups. Clinical response, deep stromal, parametrial and lymph vascular invasions were independent risk factors for lymph node metastasis in the NACT group. Furthermore, deep stromal invasion and lymph vascular invasion, but not the response to NACT, were independently associated with upper LNM. The number of lymph nodes involved, response to NACT, tumor histology and a positive vaginal margin were independent prognostic factors affecting DFS or OS rates in node-positive patients treated with NACT plus radical surgery.

CONCLUSION

The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.

摘要

背景

新辅助化疗(NACT)对宫颈癌淋巴结转移的拓扑分布模式的影响尚不清楚。

方法

纳入接受了根治性手术(无论是否接受NACT)的FIGO IB1-IIB期患者(3527例)。采用配对病例对照设计比较NACT对淋巴结转移的影响。

结果

我们分别分析了配对的初次手术组和NACT组中被诊断为淋巴结转移的167例和140例患者,未观察到显著差异(p = 0.081)。与无反应组相比,NACT反应组的淋巴结转移发生率显著降低(18.4%对38.6%,P<0.001)。除腹股沟深部和主动脉旁淋巴结组外,NACT反应组中每个淋巴结组的转移率也有所下降。临床反应、深部间质、宫旁和淋巴管浸润是NACT组淋巴结转移的独立危险因素。此外,深部间质浸润和淋巴管浸润而非对NACT的反应与上淋巴结转移独立相关。受累淋巴结数量、对NACT的反应、肿瘤组织学和阴道切缘阳性是影响接受NACT加根治性手术的淋巴结阳性患者DFS或OS率的独立预后因素。

结论

NACT不会改变淋巴结转移的频率和拓扑分布,临床无反应者的受累淋巴结更多。无论对NACT的反应如何,接受NACT加手术治疗的患者均应进行系统性广泛淋巴结清扫术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c33/4393094/4084212d2f61/pone.0123539.g001.jpg

相似文献

1
Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? A large-scale retrospective study.
PLoS One. 2015 Apr 10;10(4):e0123539. doi: 10.1371/journal.pone.0123539. eCollection 2015.
4
Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Int J Gynaecol Obstet. 2012 Apr;117(1):23-6. doi: 10.1016/j.ijgo.2011.11.017. Epub 2012 Jan 21.
5
Surgical-pathologic risk factors of pelvic lymph node metastasis in stage Ib1-IIb cervical cancer.
Acta Obstet Gynecol Scand. 2012 Jul;91(7):802-9. doi: 10.1111/j.1600-0412.2012.01415.x. Epub 2012 May 18.

引用本文的文献

1

本文引用的文献

2
Metastasis to deep obturator and para-aortic lymph nodes in 649 patients with cervical carcinoma.
Eur J Surg Oncol. 2011 Nov;37(11):978-83. doi: 10.1016/j.ejso.2011.08.128. Epub 2011 Sep 9.
7
Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer.
Gynecol Oncol. 2010 Nov;119(2):217-24. doi: 10.1016/j.ygyno.2010.06.017. Epub 2010 Aug 11.
8
Inadvertent potential risk of neoadjuvant chemotherapy in cervical cancer.
Med Hypotheses. 2009 Dec;73(6):1005-7. doi: 10.1016/j.mehy.2009.05.026. Epub 2009 Jun 23.
9
Revised FIGO staging for carcinoma of the cervix.
Int J Gynaecol Obstet. 2009 May;105(2):107-8. doi: 10.1016/j.ijgo.2009.02.009. Epub 2009 Apr 1.
10
Lymph node assessment in cervical cancer: prognostic and therapeutic implications.
J Surg Oncol. 2009 Mar 15;99(4):242-7. doi: 10.1002/jso.21199.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验